These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 26429121)
21. Incidence of additional genetic changes in the TEL and AML1 genes in DCOG and COALL-treated t(12;21)-positive pediatric ALL, and their relation with drug sensitivity and clinical outcome. Stams WA; Beverloo HB; den Boer ML; de Menezes RX; Stigter RL; van Drunen E; Ramakers-van-Woerden NL; Loonen AH; van Wering ER; Janka-Schaub GE; Pieters R Leukemia; 2006 Mar; 20(3):410-6. PubMed ID: 16424874 [TBL] [Abstract][Full Text] [Related]
22. Expression levels of TEL, AML1, and the fusion products TEL-AML1 and AML1-TEL versus drug sensitivity and clinical outcome in t(12;21)-positive pediatric acute lymphoblastic leukemia. Stams WA; den Boer ML; Beverloo HB; Meijerink JP; van Wering ER; Janka-Schaub GE; Pieters R Clin Cancer Res; 2005 Apr; 11(8):2974-80. PubMed ID: 15837750 [TBL] [Abstract][Full Text] [Related]
23. The presence of TEL/AML1 rearrangement and cryptic deletion of the TEL gene in adult acute lymphoblastic leukemia (ALL). Lee DS; Kim YR; Cho HK; Lee CK; Lee JH; Cho HI Cancer Genet Cytogenet; 2005 Oct; 162(2):176-8. PubMed ID: 16213368 [TBL] [Abstract][Full Text] [Related]
24. The TEL-AML1 fusion protein of acute lymphoblastic leukemia modulates IRF3 activity during early B-cell differentiation. de Laurentiis A; Hiscott J; Alcalay M Oncogene; 2015 Dec; 34(49):6018-28. PubMed ID: 25893288 [TBL] [Abstract][Full Text] [Related]
25. The TEL-AML1 leukemia fusion gene dysregulates the TGF-beta pathway in early B lineage progenitor cells. Ford AM; Palmi C; Bueno C; Hong D; Cardus P; Knight D; Cazzaniga G; Enver T; Greaves M J Clin Invest; 2009 Apr; 119(4):826-36. PubMed ID: 19287094 [TBL] [Abstract][Full Text] [Related]
26. Defining the oncogenic function of the TEL/AML1 (ETV6/RUNX1) fusion protein in a mouse model. Fischer M; Schwieger M; Horn S; Niebuhr B; Ford A; Roscher S; Bergholz U; Greaves M; Löhler J; Stocking C Oncogene; 2005 Nov; 24(51):7579-91. PubMed ID: 16044150 [TBL] [Abstract][Full Text] [Related]
27. Persistence of TEL-AML1 fusion gene as minimal residual disease has no additive prognostic value in CD 10 positive B-acute lymphoblastic leukemia: a FISH study. Mosad E; Hamed HB; Bakry RM; Ezz-Eldin AM; Khalifa NM J Hematol Oncol; 2008 Oct; 1():17. PubMed ID: 18928518 [TBL] [Abstract][Full Text] [Related]
28. Detection of concurrent TEL-AML1/TEL-ABL fusion genes in a patient with B-acute lymphoblastic leukemia using a multi-fusion gene qRT-PCR screening method. Zhang J; Mao S; Su S; Wei L; Li T; Liu Y Pathol Int; 2016 Aug; 66(8):475-7. PubMed ID: 27418307 [No Abstract] [Full Text] [Related]
29. TEL/AML1 fusion gene in childhood acute lymphoblastic leukemia in southern Taiwan. Lin PC; Chang TT; Lin SR; Chiou SS; Jang RC; Sheen JM Kaohsiung J Med Sci; 2008 Jun; 24(6):289-96. PubMed ID: 18635414 [TBL] [Abstract][Full Text] [Related]
30. [The role of TEL and AML1 genes in the pathogenesis of hematologic malignancies]. Zuna J Cas Lek Cesk; 2001 Mar; 140(5):131-7. PubMed ID: 11347199 [TBL] [Abstract][Full Text] [Related]
31. The AML1 gene: a transcription factor involved in the pathogenesis of myeloid and lymphoid leukemias. Lo Coco F; Pisegna S; Diverio D Haematologica; 1997; 82(3):364-70. PubMed ID: 9234595 [TBL] [Abstract][Full Text] [Related]
32. Prevalence of TEL/AML1 fusion gene in Brazilian pediatric patients with acute lymphoblastic leukemia. Zen PR; Lima MC; Coser VM; Silla L; Daudt L; Fernandes MS; Neumann J; Mattevi MS; Ortigara R; Paskulin GA Cancer Genet Cytogenet; 2004 May; 151(1):68-72. PubMed ID: 15120912 [TBL] [Abstract][Full Text] [Related]
33. [Immunophenotypic characteristics of children with acute lymphoblastic leukemia carrying TEL-AML1 fusion gene]. Liu Y; Li ZG; Zhao W; Li B; Gong WY; Wu MY Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Aug; 14(4):714-6. PubMed ID: 16928306 [TBL] [Abstract][Full Text] [Related]
34. TEL/AML1-positive patients lacking TEL exon 5 resemble canonical TEL/AML1 cases. Zaliova M; Meyer C; Cario G; Vaskova M; Marschalek R; Stary J; Zuna J; Trka J Pediatr Blood Cancer; 2011 Feb; 56(2):217-25. PubMed ID: 21157892 [TBL] [Abstract][Full Text] [Related]
36. Hemophagocytosis by leukemic blasts in B lymphoblastic leukemia with t(12;21)(p13;q22); TEL-AML1 (ETV6-RUNX1): a case report. Park JE; Park IJ; Lim YA; Lee WG; Cho SR Ann Clin Lab Sci; 2013; 43(2):186-9. PubMed ID: 23694795 [TBL] [Abstract][Full Text] [Related]
38. ETV6/RUNX1 rearrangement in childhood B-precursor acute lymphoblastic leukemia with normal karyotypes or without cytogenetic results. Alvarez Y; Gaitán S; Perez A; Bastida P; Ortega JJ; Dastugue N; Robert A; Aventín A; Badell I; Guitart M; Melo M; Caballín MR; Coll MD Cancer Genet Cytogenet; 2004 Jul; 152(1):77-80. PubMed ID: 15193447 [TBL] [Abstract][Full Text] [Related]
39. Chromosomal changes detected by fluorescence in situ hybridization in patients with acute lymphoblastic leukemia. Zhang L; Parkhurst JB; Kern WF; Scott KV; Niccum D; Mulvihill JJ; Li S Chin Med J (Engl); 2003 Sep; 116(9):1298-303. PubMed ID: 14527352 [TBL] [Abstract][Full Text] [Related]
40. Immunogenotype changes prevail in relapses of young children with TEL-AML1-positive acute lymphoblastic leukemia and derive mainly from clonal selection. Panzer-Grümayer ER; Cazzaniga G; van der Velden VH; del Giudice L; Peham M; Mann G; Eckert C; Schrauder A; Germano G; Harbott J; Basso G; Biondi A; van Dongen JJ; Gadner H; Haas OA Clin Cancer Res; 2005 Nov; 11(21):7720-7. PubMed ID: 16278392 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]